Skip to content

Drug interactions

Sofosbuvir-velpatasvir-voxilaprevir + Tecovirimat

Severity: Minor

Sofosbuvir-velpatasvir-voxilaprevir and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat weakly inhibits CYP2C8 and CYP2C19 and may weakly induce CYP3A4. Changes in velpatasvir and voxilaprevir exposure are expected to be small and clinically modest.

What this interaction means in plain words

Sofosbuvir-velpatasvir-voxilaprevir and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak inhibition of CYP2C8/CYP2C19 and weak CYP3A4 induction by tecovirimat may slightly alter velpatasvir and voxilaprevir metabolism.

What to do

No dose adjustment is usually needed. Monitor for adverse effects of the antiviral regimen during the short tecovirimat course.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sofosbuvir-velpatasvir-voxilaprevir and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sofosbuvir-velpatasvir-voxilaprevir with Tecovirimat?

MediHelp rates the interaction as minor. Sofosbuvir-velpatasvir-voxilaprevir and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat weakly inhibits CYP2C8 and CYP2C19 and may weakly induce CYP3A4. Changes in velpatasvir and voxilaprevir exposure are expected to be small and clinically modest.

How serious is the interaction between Sofosbuvir-velpatasvir-voxilaprevir and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is usually needed. Monitor for adverse effects of the antiviral regimen during the short tecovirimat course.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in